A Sarepta antisense drug that targets a single ebolavirus protein successfully protected 75% of the rhesus monkeys it was given to, offering some solid animal data to back up the biotech’s claim that it has an effective antidote to the lethal disease.

…read more

Source: Sarepta sees promising signs that antisense drug can guard against Ebola


0 No comments